Belvedere Trading
MESO

Belvedere Trading’s Mesoblast MESO Stock Holding History

Belvedere Trading’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,027
Closed -$70.6K – 830
2023
Q2 		$70.6K Buy
9,027
+7,125
+375% +$50.9K ﹤0.01% 498
2023
Q1 		$12.5K Buy
1,902
+1,011
+113% +$6.69K ﹤0.01% 739
2022
Q4 		$5.19K Buy
+891
New +$5.57K ﹤0.01% 977

Other funds holding MESO

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $287M AUM 28.24% 1-Year Est. Return

Belvedere Trading's MESO Position: Q3 2023 in Review

Belvedere Trading sold out of Mesoblast (MESO) in Q3 2023, closing a stake of 9,027 shares — an estimated $70.6K sold.

Belvedere Trading first reported a position in MESO in Q4 2022 and held it in 3 quarters. The position peaked at $70.6K in Q2 2023. 35 funds tracked by Wall St. Rank hold MESO as of Q3 2023.

  • Belvedere Trading reported no remaining Mesoblast position as of Q3 2023 after selling out during the quarter.
  • Belvedere Trading sold 9,027 Mesoblast shares in Q3 2023, an estimated $70.6K.
  • Belvedere Trading first reported a position in Mesoblast in Q4 2022 and held it in 3 quarters.
  • Belvedere Trading's Mesoblast position peaked at $70.6K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held Mesoblast as of Q3 2023.

Based on Belvedere Trading's 13F filing for Q3 2023, filed 27 Oct 2023.